Craig Adeyanju

InvestorPlace Contributor

Craig Adeyanju enjoys to unearth awesome growth and value stocks and educate investors about the companies behind them. He believes that the best companies to invest in are those that genuinely solve a problem.

His work has appeared on sites like TheStreet, The Motley Fool, Benzinga among others.

Recent Articles

Yahoo Stock: Is Marissa Mayer Anathema for YHOO?

By Craig Adeyanju, InvestorPlace Contributor

The progress Yahoo stock is making under Mayer is quite slow. However, YHOO has a host of underutilized assets that could make it great.

AZN: Why AstraZeneca’s Current Dip Is a Buying Opportunity

By Craig Adeyanju, InvestorPlace Contributor

Astrazeneca has been investing aggressively in immuno-oncology, which will make AZN stock much more attractive in the long run.

U.S. Debut of Biosimilar Drugs Threatens Major Biotechs

By Craig Adeyanju, InvestorPlace Contributor

The introduction of biosimilar drugs will change the biotech landscape ... especially for these three names.

TGT Stock: Target Beacons Are a Move in the Right Direction

By Craig Adeyanju, InvestorPlace Contributor

Target beacons should help TGT improve margins, sales and earnings, thus improving already solid fundamentals for Target stock.

Stocks to Buy: Hecla Mining (HL) Is a Cost Saving Machine

By Craig Adeyanju, InvestorPlace Contributor

Hecla mining has been doing a good job keeping its cash cost in check under all precious metal landscape. Investors should consider HL stock a buy.

Load More